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In recent years, various biochemical investigation
techniques, e.g. determination of total estrogens
in 24-hour urine, of unconjugated estriol (E3),
HPL and other placental steroids in the serum have
been applied to a large scale to monitor feto-
placental or placental function [2, 6, 115 12, 20].
However, up to the present no single parameter
has proved to be the method of choice, probably
due to the fact that complex enzymatic Systems or
various organs are involved in the synthesis of
steroid or protein hormones.
Estetrol (15a-estriol, E4) is a specific product of
fetal metabolism. The last synthetic Steps depend
on the hydroxylation capacity of the fetal liver.
Important precursors of E4 synthesis are estradiol-
170 and to a smaller extent neutral C19 steroids of
the fetoplacental unit [16, 18, 21]. From the
fetus, the hormone passes into the maternal circula-
tion and is mainly excreted äs E4-glucuronide in
the urine [3].
First investigations in the urine and later also in
the blood have shown that this steroid can be
regarded äs a good indicator of the fetal state in
intrauterine danger [5, 9, 19]. By obtaining spe-
cific antisera to E4, it has become possible in
recent years to determine the low concentration of
this steroid in the serum radioimmunologically
without time consuming and technically elaborate
Separation methods [l, 4, 8, 16, 22]. The objec-
tive of the present investigation therefore is to
establish in a larger group of patients whether the
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determination of unconjugated E4 is superior to
the measurement of other steroids especially in
intrauterine growth retardation, since the signifi-
cance of hormone assays is chiefly in the diagnosis
of intrauterine growth disorders, and can thereby
lead to an improvement of the detectiön of fetal
danger states.
l Materials and methods
1.1 Assay methods
The concentration of unconjugated serum E4 is
determined radioimmunologically with some mod-
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ifications äs described by KÜNZIG and GEIGER for
E3 [10, 11]. The antiestetrol antiserum was kindly
provided by Dr. P. G. D. DEAN [16]. The cross-
reaction against E3 is 0.4%, and against all other
steroids less than 0.1%.
The method can be described briefly äs follows:
0.5 ml of serum are extracted mechanically with
10 ml diethylether for 10 minutes. The tubes are
then placed in a methanol bath (- 25 °C). After
freezing the aqueous phase, the ether is poured
into glass test tubes and evaporated with nitrogen.
The residue is dissolved with 0.3 ml of ethanol and
2 X 0.1 ml transferred into disposable glass test
tubes. The alcohol is evaporated once more and
0.1 ml 2.4-3H-E4 (specific activity 49 Ci/mM
(NEN), 2 X 10"* Mol), äs well äs 0.2 ml -globulin
(5 mg/ml) and 0.2 ml anti-E4 antiserum (l: 14,000)
are added (dissolved in phosphate-buffered saline).
The test mixtures are incubated for 30 minutes
at roöm temperature and at 4 °C, respectively. The
antibody-bound and free steroid is separated by
addition of 0.5 ml of a charcoal-dextran mixture
with subsequent centrifugation. Afterwards, the
antibody-bound radioactivity present in the super-
natant is measured in a liquid-scintillation counter
and the hormone concentration determined with
reference t o a Standard curve. The calculation is
performed with the aid of a Computer program by
means of spline approximation (Fa. BERTHÖLD).
The recovery of unlabeled steroids, added to
steroid free serum, is 91.9% (n = 22). The intra-
assay Variation is 8.4% (n = 10) and the interassay
precision is 14.8% (n = 10). The lower limit of
sensitivity of the Standard curve is 20 pg E4.
1.2 Patients investigated
1.2.1
The reference ränge for E4 is determined by 279
determinations between the 22nd and 40th week
of pregnancy. The samples derive from different
outpatients and inpatients in a random sequence.
Any pathology of pregnancy has been excluded.
1.2.2
To determine the variability of the serum level of
E4, blood was taken from three patients over four
hours at an interval of 15 minutes and over 24
hours at an interval of 60 minutes, in 22 patients
over 24 hours at an interval of four hours, äs well
äs in four patients on five or six consecutive days.
1.2.3
In five patients, the serum E4 level is determined
before, during and after application of beta-
methasone (8, 8, 4, 4 mg on four consecutive
days), in seven patients who had received an intra-
venous tocolysis with beta-sympathomimetics, äs
well äs in six patients before and up to four days
after commencement of a therapy with ampicillin.
1.2.4
A group of 151 patients delivered of babies with
signs of intrauterine growth retardation was also
investigated. The neonates were subdivided into
"small for dates" below the 25th percentile and
'Very small for dates" below the lOth percentile
according to LUBCHENKO [13], äs well äs into
neonates with and without signs of dystrophy. The
25th and lOth percentile of the weightcharts of
LUBCHENKO are comparable to the lOth and 3rd
percentile of the weightcharts of NICKL [2]. Twen-
ty-two and 24 highly retarded eutrophic and
dystrophic babies (very small for dates) respect-
ively äs well äs 75 and 24 slightly retarded eutro-
phic and dystrophic neonates (small for dates)
respectively are found. For 55 of the 151 patients,
three and more values are between the 30th and
40th week of pregnancy, so that an observation on
the concentration course of E4 is possible. This is
made on the basis of the following criteria:
1.2.4.1
E4 concentration primarily below the normal
ränge.
1.2.4.2
Decrease of the E4 level by more than 35% within
the last t wo weeks of pregnancy.
1.2.4.3
Rising concentration, i.e. corresponding to nor-
mal.
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The results are compared with the values of the
unconjugated E3 determined according to the
method of KÜNZIG and GEIGER [10512].
2 Results
The serum level of unconjugated E4 is 0.27 ±
0.06 ng/ml in the 22nd week of pregnancy and
rises to 1.37 ± 0.65 ng/ml towards the end of
pregnancy. However, a sharper rise of the values
only occurs from about the 30th week of preg-
nancy. There is an appreciable Variation of the
individual values (n = 279) of the various patients
around the mean value (Fig. 1).
The variability of the serum concentrations of E4
, is investigated by blood samples taken at 15 min-
ute to 24 hour intervals (see methods). The mean
coefficient of Variation is a minimum of 11.7 ±
4.3% and a maximum of 16.3 ± 9.5% (Tab. I). It





Tab. I. Fluctuations of unconjugated estetrol.
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Fig. 1. Serum concentration of unconjugated estetrol.
Individual levels (n = 279) and mean values between the



























within or between the series. A diurnal rhythm
cannot be demonstrated over a period of 24 hours;
only an undulating fluctuation is detectible.
(Fig. 2).
Drugs such äs corticosteroids, 0-sympathomimetics
or antibiotics show a distinct influence on the
serum E4 concentration. Within a few hours, there
is a decline by an average of 30% compared to the
mean initial concentration. With continuation of
therapy, the initial value is regained after two to
three days with ß-sympathomimetics and after five
days with ampicillin, whereas a fresh rise of the
values can only be observed after discontinuation
of the treatment with corticosteroids (Tab. II).
With intrauterine growth retardation below the
lOth percentile, the E4 concentration in the serum
displays a characteristic course. As can be seen
from Fig. 3b, no appreciable alteration of the
values can be detected especially in the last five
weeks of pregnancy, in which there is normally a
rise of serum E4 values. At the end of pregnancy,
the mean value for 'Very small for dates" (n = 30)
with signs of dystrophy is 0.93 ng/ml. For children
of the same size without signs of dystrophy
(n = 22), it is 0.86 ng/ml, corresponding to 60-
70% of the normal. A similar course can also be
recognized in "small for dates" with signs of
dystrophy (n = 24) (Fig. 3a). The mean value at
the end of pregnancy is 0.83 ng/ml and is thus
about 40% below the normal for this stage of
pregnancy. On the other hand, the serum level in
"small for dates" without signs of dystrophy
(n = 75) approximates more to the region of the
normal curve and at the end of pregnancy a con-
centration of 1.20 ng/ml can be detected, i.e. the
curve of the mean values practically corresponds
to that of babies which have developed normally
(Fig.3a).
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Fig. 2. Fluctuations of free estctrol over a 24 hour period in thrcc patients.
Tab. II. Serum concentration of £4 in percent of initial valucs und er (he influence of various drugs.
hours after commcnccmcnt of therapy
2 4 8 24 48 72 96 120
Betamethasone
(n = 5)
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Fig. 3. Serum concentrations of unconjugated estetrol (mean valucs) in intrauterinc growth retardation below
a.) the 25th
b.)the lOth percentile of LUBCHENKO et al. [14]. The solid lines represenl the 90th, 50th, and lOth percontile in
normal pregnancy.
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However, mean values can only indicate a tend-
. ency and for recognition of the diagnostic value of
a method it appears meaningful to register the
concentration course of individual patients. As
can be seen frpm Table 3, in "very small for dates"
with signs of dystrophy pathological courses are
present in 70% and in those without signs of
dystrophy in 86%. Slightly retarded dystrophic
babies frequently also display pathological values
(in 66%), whereas eutrophic neonates of the
same size reveal normal E4 levels in 84%.
A comparison of the measurement of the well
established method of free E3 compared to E4 in
routine clinical tests shows that pathological E4 or
• r
E3 values can be detected in eight out of 31 or
eight out of 29 "small for dates" respectively. On
the other hand, in severe retardation pathological
E4 or E3 values can be detected in 18 and 17 out
24 babies (Tab. III). A normal concentration of the
two hormones can be detected only in three cases
out of the "very small for dates", so that in this
group thefe is suspicion of an intrauterüie growth
retardation in 88% of the cases of this group on
the basis of the measurement of both hormones.
As a whole, a divergent course of the two hor-
mones can nevertheless be detected in 13 out of
53 cases (25%) (Tab. IV).
Tab. III. Serial serum E4 and E3 levels in intrauterine growth retardation.
VERY SMALL FOR DATES
Dystrophy Eutrophy































































































Tab. IV. Serial serum E4 levels in comparison to the concentration course of £3 in intrauterine growth retardation.
VERY SMALL FOR DATES
Dystrophy Eutrophy
No. of patients
Suspicious values E4 + E3
Suspicious values
E4 + regulär values E3
Suspicious values
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3 Discussion
Our results show that with specific antisera to E4,
the radioimmunological determination of this
steroid can be used äs a routine method for sur-
veillance of risk pregnancies.
From the 22nd to the 30th week of pregnancy,
the serum level of E4 practically does not change
with values between 0.24 and 0.37 ng/ml. Then
a rise follows, which is intensified once again after
the 36th week of pregnancy (surge point) up to
the end of pregnancy [9]. Here, the mean value is
1.37 ng/ml. Our values are in accordance with
those of other authors [1,9, 18,21] who likewise
use specific antisera. Only KORDA [7] reports
extremely high concentrations around 5 ng/ml at
the end of pregnancy; these must be regarded äs
methodological in origin.
Even with more frequent blood samples, we were
unable to detect a diurnal rhythm äs was already
suspected by TULCHINSKY et al. [19] äs well äs
NOTATION and TAGATZ [15]. Only uncharacteris-
tic fluctuations with a mean coefficient of Varia-
tion between 11.7 and 14.5% are found. The day-
to-day fluctuations (16.3%) are also in a similar
ränge. They thus do not differ significantly from
the precision in the series and between the series.
Thus the variations of E4 correspond over short
and long time intervals to those of other estrogens
and peptides in maternal blood [2, 11], The daily
fluctuations of NOTATION and TAGATZ [15] with
in some cases 70% appear inexplicably high; how-
ever, an assay method with an unspecific anti-
serum äs well äs Chromatographie Separation was
employed.
After application of drugs äs corticosteroids, ß-
sympathomimetics or antibiotics (frequently ad-
ministered in pathological pregnancies), there is a
rapid decrease of E4 concentrations of about
30%, although the values can rise again already
under administration of the two latter drugs.
These findings correspond to the results already
obtained for E3 on a large scale and appear to be
due to comparable pathomechanisms [11]. From
this there result important consequences for the
Interpretation of the hormone determination in
the hospital during treatment with the substances
specified above: the absence of a fresh rise or a
continuous decrease of the E4 concentration is
not due to therapy, but must be regarded äs a sign
of deterioration of fetoplacental function.
Since the significance of hormone assays is chiefly
in the diagnosis of intrauterine growth disorders,
the value of the measurement of E4 is depicted in
the diagnosis of intrauterine growth retardation
and the fetal danger states associated with this. In
"small for dates" and "very small for dates" with
signs of dystrophy, in particular the rise normally
taking place in the last weeks of pregnancy cannot
be detected and at the end of pregnancy the values
are only about 60-70% of those of the normal
group (Fig. 3a + b). In contrast to this, the serum
concentration in eutrophic "small for dates" is
very much nearer to the normal curve, since these
involve genetically small babies withoüt appreci-
able signs of an intrauterine growth disorder
(Fig. 3a).
However, single values can be regarded only äs a
"screening test" and a reliable evaluation of the
fetoplacental unit is only possible on the basis of
serial determinations. Here it is shown that primar-
ily pathological values (< lOth percentile) or a
significant decrease of the concentration (> 35%)
within the last two weeks of pregnancy indicate a
fetal retardation or an acute deterioration of feto-
placental function. This applies to 75% of the
"very small for dates" with and withoüt signs of
dystrophy (Tab. III).
A significant decrease of the E4 level was also ob-
served by TULCHINSKY et al. [19] in seven patients
with severe pre-eclampsia and subsequent fetal
death, whereas KUNDU et al. [9] assert a superior-
ity to E4 compared to determination of E3 and
HPL on the basis of comparative sequential observ-
ations. The results of NOTATION and TANGATZ
[15] appear to us and also to other authors [9] to
be difficult to Interpret already for methodological
reasons. Our comparative serial investigations of
the assay of E4 and E3 in a group of 53 pregnancies
with fetal retardation show that the number of
suspicious curves of E4 and E3 in intrauterine
growth retardation is roughly the same and thus
the information conveyed is similar (Tab. III).
However, only 14 out of 24 highly retarded babies
display pathological courses of bothsteroids where-
as in a further seven neonates of the same group
only one hormone appears to be suspicious. Thus a
J.Perinat.Med. 9(1981)
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severe intrauterine growth retardation could be
detected with a joint determination in 88% com-
pared to 75% and 71% respectively when E4 or E3
was measured alone.
Determination of £4 alone thus does not provide a
fundamentally new possibility of prenatal dia-
gnosis of jntrauterine growth disorders. However,
E4 appears to be a further diagnostic adjunct
similar to E3 to a certain extent, and use of which
can provide a further improvement of our dia-
gnosis. The precondition for this is a further
simplification of the laboratory methods, so that
after automated determination the joint considera-
tion of various diagnostic methods (similar to in-
ternal medicine) enables an early and certain
appraisal of the fetal state.
Summary
Within recent years various biochemical tests have been
used extensively for assessing the placental and the feto-
placental function. However, atpresent,no single hormone
assay seems entirely adequate for this purpose, since com-
plex enzymatic Systems and different organs are involved
· \ in the production of steroid and peptide hormones. Este-
trol is considered to be a specific product of the fetal liver.
With the recent availability of specific antisera to estetrol
it has become possible to measure the small quantities of
this steroid by radioimmunoassay without the require-
ment for prior Chromatographie Separation Steps. Thereby
the determination of estetrol can be used äs a routine
method on a large scale in high risk pregnancies. In this
study we investigated, whether the measurement of this
steroid may improve the surveillance of risk pregnancies,
especially those complicated by intrauterine growth re^
tardation and thereby contribute to the solution of some
of the still unsolved problems.
The serum concentration of unconjugated estetrol in-
creases from 0,27 ng/ml in the 22nd week of pregnancy
to 1,37 ng/ml at term. However, mean values only Start to
rise more rapidly after the 30th week of gestation. The
results of serial determinations at 15 min. to 24 hour
intervals show slight fluctuations with no consistent
pattern, the mean coefficients of Variation being minimal
11,7%, maximal 16,3%. No diurnal Variation is apparent.
Corticosteroids, 0-mimetic drugs and antibiotics cause an
immidiate drop of the estetrol concentrations to about
70% of the initial values. Therefore estetrol exhibits a
similar behavior to that of estriol under the influence of
various drugs especially used in risk pregnancies and this
has to be taken into account in hormonal moriitoring.
The most marked changes in the concentration of estetrol
are seen in intrauterine growth retardation. It can be ob-
served that especially in very small for dates with and
without signs of dystrophy the physiological rise in the
last weeks of pregnancy is absent and the curve remains
flat. At the end of gestation, mean values average 60-70%
of the levels in regulär pregnancy. The same trend applies
to less retarded childreri also häving signs of dystrophy.
Serial determinations in 55 cases complicated by intrau-
terine growth retardation demonstrate, that 70% and
86% of very small for dates with and without signs of
dystrophy show a suspicious hormonal pattern. Similar
figures (66%) are seen in less retarded children with signs
of dystrophy, too. On the contrary, in slightly retarded
eutrophic babies, regulär levels can be depicted in 84%.
Comparing results of estetrol and estriol determinations
show, that the two estrogens give a similar Information of
the fetal state. However, in 25% the hormone profiles
may differ. By joint determination of both steroids,
suspicious values are depicted in 88% to 70-75% by
single measurement of either hormone. Therefore the
determination of estetrol can not replace other bio-
chemical tests of feto-placental function but is an addi-
tional adjunct in the detection of intrauterine growth-
retardation. It enables further improvement of the ante-
natal diagnosis of this complication of pregnancy.
Keywords: Drugs, estetrol, estriol, fluctuations, intrauterine growth retardation, normal pregnancy, radioimmuno-
assay.
Zusammenfassung
Wertigkeit der Bestimmung von Östetrol bei der Dia-
gnostik der intrauterinen Mangelentwicklung.
Vergleich mit unkojungiertem Östriol.
In den letzten Jahren sind verschiedene biochemische Un-
tersuchungsverfahren in großem Umfang zur Überwachung
der placentaren bzw. fetoplacentaren Funktion angewandt
worden. Allerdings hat sich bis zum gegenwärtigen Zeit-
punkt kein einzelner dieser Parameter als die Methode der
Wahl erwiesen, da komplexe enzymatische Systeme oder
verschiedene Organe an der Synthese von Steroiden und
Peptiden beteiligt sind. Östetrol ist ein spezifisches Pro-
dukt des fetalen Leberstoffwechsels. Die Gewinnung spe-
zifischer Antiseren gegen Östetrol hat es ermöglicht, die
niedrige Konzentration dieses Steroids im Blut unter Aus-
lassung zeitraubender und technisch aufwendiger Tren-
nungsmethodeii radioimmunologisch zu bestimmen. Hier-
durch kann die Messung dieses Steroids als Routine-
methode für die Überwachung von Risikoschwangerschaf-
ten herangezogen werden, in der vorliegenden Arbeit wird
geprüft, ob die Bestimmung des freien Östetrol im Blut zu
einer Verbesserung der bisherigen antenatalen Diagnostik
speziell der intrauterinen Mangelentwicklung beitragen
kann.
Der Serumspiegel des freien Östetrol steigt bei einem un-
ausgewählten Patientengut von 0,f27 ng/ml in der 22.
Schwangerschaftswoche auf 1,37 ng/ml am Ende der Gra-
J.Perinat.Med. 9(1981)
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vidität an. Dabei erfolgt der Konzentrationsanstieg vorwie-
gend innerhalb der letzten 10 Schwangerschaftswochen.
Bei Messung des Östetrolspiegels in 15 min. bis 24 std.
Abständen finden sich unspezifische Fluktuationen mit
mittleren Variationskoeffizienten von minimal 11,7%,
maximal 16,3%; ein diurnaler Rhythmus kann nicht nach-
gewiesen werden. Medikamente wie Kortikosteroide, ß-
Sympatomimetika oder Antibiotika fuhren innerhalb
weniger Stunden zu einem Absinken der östetrolkonzen-
tration von durchschnittlich 30% und lassen damit ein
dem Östriol ähnliches Verhalten erkennen. Dies muß bei
der hormonelien Überwachung in Betracht gezogen
werden.
Bei intrauteriner Mangelentwicklung weist die E4-Kon-
zentration einen charakteristischen Verlauf auf. Der beson-
ders in den letzten Schwangerschaftswochen erfolgende
Anstieg ist nicht feststellbar und am Ende der Tragzeit
entspricht der Mittelwert sowohl bei stark retardierten
Kindern mit und ohne Dystrophiezeichen als auch bei
leicht retardierten dystrophen Neugeborenen 60-70% der
Norm. Retrospektive Verlaufsuntersuchungen von 55
Schlüsselwörter: Fluktuationen, intrauterine Mangelentwicklung, Medikamente, normale Schwangerschaft, Östetrol,
Östriol, Radioimmunoassay.
Schwangerschaften mit intrauterinen Wachstumsstörun-
gen zeigen: Bei schwerer Retardierung mit und ohne Dy-
strophiezeichen liegen in 70% bzw. 86% pathologische
Verläufe vor, mit 66% weisen auch leicht retardierte dy-
strophe Kinder häufig suspekte Werte auf. Dagegen lassen
nur gering retardierte eutrophe Neugeborene in 84% nor-
male Steroidspiegel erkennen. Ein Vergleich der in der
klinischen Routine erprobten Messung des freien Östriol
gegenüber Östetrol läßt erkennen, daß die Aussagefähig-
keit von Östriol und Östetrol ähnlich ist. Allerdings
kann in 25% ein divergenter Verlauf vorliegen. Durch
gemeinsame Bestimmung beider Steroide läßt sich ein
suspekter Verlauf bei schwerer Retardierung in 88%
feststellen gegenüber 70-75% bei alleiniger Messung eines
der Hormone. Somit ersetzt die Messung von Östetrol
nicht die der bisher erprobten biochemischen Parameter
sondern scheint ein zusätzlicher Mosaikstein in der Dia-
gnostik intrauteriner Wachstumsstörungen zu sein, der
in Verbindung mit diesen zu einer weiteren Verbesserung
der antenatalen Diagnostik beitragen kann.
Resume
La valeur de Festimation de oestetrol pour le diagnostic
de la defience de croissance intra-uterine.
Comparee avec Foestriol non-conjuge.
Durant ces dernieres annees de differentes methodes bio-
chimiques fürent appliquees a grande echelle pour la sur-
veillance de la fonction placentaire oü la fonction foeto-
placentaire. Jusqu'a present aucun de ces parametres ne
pouvait etre considere comme la meilleure, parce que des
systemes enzymatiques cpmplexes ou des organes diffe-
rents sont responsables de la synthese des steroides et des
peptides. L'oestetrol est un produit speciflque du meta-
bolisme hepatique foetal. L'extraction d'un anti-serum
specifique d Oestetrol a permis de mesurer par methode
radioimmunologique une concentration minime dans le
sang, en evitant des methodes de Separation compliquees.
Donc la mesure de ce steroid peut etre utilisee comme
methode de routine pour la surveillance de grossesses a
haut risque.
Dans ce travail-ci on a examine si Festimation d'oestetrol-
libre dans le sang pouvait etre une amelioration du dia-
gnostic antenatal contemporain, specialement pour le cas
de defience de croissance intra-uterine. Le taux le serum
d'oestetrol-libre monte de 0,27 ng/ml au moment de la
22me semaine de grossesse jusqu'a 1,37 ng/ml a la fin de
la grossesse, mesure dans un lot de patients pris au hasard.
De la il s'ensuit que la montee de la concentration se pio-
duit surtout durant les 10 dernieres semaines. Par la
mesure de taux d'oestetrol dans un delai de 15 min a 24
heures, on trouve des fluctuations nonspecifiques avec un
coefficient de Variation moyen d'un minimum de 11,7%
et comme maximum 6,3%; un rythme diurne ne peut-
etre prouve.
Des medicaments, comme les corticosteroides, les ß-
sympaticomimetiques ou les antibiotiques induisent ende-
Mots-cles: fluctuations, troubles de croissance intra-uterine, medicaments, oestetrol, oestriol, grossesse normale, radio-
immunoassay.
ans peu d'heures une chute de la concentration d'oestetrol
d'une valeur moyenne de 30% et produisent un effet com-
parable a celui produit sur lOestriol. On doit en tenir
compte dans la surveillance hormonale. Dans la deficience
de croissance intra-uterine, la concentration d'E-4 montre
un trace caracteristique. L'augmentation durant les der-
nieres semaines de grossesse n'est pas retrouvee.
A la fin de la grossesse la valeur moyenne ne represente
que 60-70% des normes chez les enfants fortement
retardes avec ou sans signes de dystrophie ainsi que chez
des nouveau-nes dystrophiques legerement retardes.
La retrospective des examens de 55 grossesses presentant
des troubles de croissances intra-uterines, a montre: dans
les cas d'enfants gravement retardes avec ou sans signes
de dystrophie il y avait de 71% a 86% de traces patho-
logiques, des enfants dystrophiques legerement retardes
avaient des valeurs suspectes dans 66% des cas.
Des nouveau-nes eutrophes legerement retardes presen-
taient dans 84% des cas des taux de steroides normaux.
En comparant lors de mesures de routine en clinique,
l'oestriol-libre avec l'oestetrol on en deduit que Foestriol
et l'oestetrol donnent presque la meme valeur clinique,
neanmoins on peut trouver dans 25% des cas une suite
divergente. Par la mesure des deux hormones on en arrive
a une estimation de 88% des cas suspectes chez les retardes
graves, contre 70—75% par le mesure d'une seule hor-
mone. L'estimation d'oestetrol ne remplace les para-
metres biochimiques utüises jusqu'ä present mais semble
etre un test supplementaire dans le diagnostic des troubles
de croissance intra-uterine en ameliorant le diagnostic
antenatal.
J.Perinat. Med.9 (1981)
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